Cargando…
Eliminating Factor H-Binding Activity of Borrelia burgdorferi CspZ Combined with Virus-Like Particle Conjugation Enhances Its Efficacy as a Lyme Disease Vaccine
The spirochete Borrelia burgdorferi is the causative agent of Lyme disease, the most common tick-borne disease in the US and Europe. No potent human vaccine is currently available. The innate immune complement system is vital to host defense against pathogens, as complement activation on the surface...
Autores principales: | Marcinkiewicz, Ashley L., Lieknina, Ilva, Kotelovica, Svetlana, Yang, Xiuli, Kraiczy, Peter, Pal, Utpal, Lin, Yi-Pin, Tars, Kaspars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809437/ https://www.ncbi.nlm.nih.gov/pubmed/29472926 http://dx.doi.org/10.3389/fimmu.2018.00181 |
Ejemplares similares
-
CspA from Borrelia burgdorferi Inhibits the Terminal Complement Pathway
por: Hallström, Teresia, et al.
Publicado: (2013) -
Crystal structure of the membrane attack complex assembly inhibitor BGA71 from the Lyme disease agent Borrelia bavariensis
por: Brangulis, Kalvis, et al.
Publicado: (2018) -
Borrelia burgdorferi (Lyme Disease)
por: Shapiro, Eugene D.
Publicado: (2014) -
Borrelia burgdorferi elongation factor EF-Tu is an immunogenic protein during Lyme borreliosis
por: Carrasco, Sebastian E, et al.
Publicado: (2015) -
Borrelia burgdorferi basic membrane proteins A and B participate in the genesis of Lyme arthritis
por: Pal, Utpal, et al.
Publicado: (2008)